Week of August 16, 2004 Project Watch |
|
LOOKING FOR A PREVIOUS STORY? CHECK THE
ARCHIVE.
R&D Jobs in SE Pennsylvania by JACK LYNE, Site Selection Executive Editor of Interactive Publishing NORTH WALES, Pa.
Merck & Co. has prescribed a strong growth
pill for its already formidable work-force cluster in Montgomery
County, Pa.: The pharmaceutical giant is adding 800 new research
positions in a two-stage, $200-million expansion, Margaret McGlynn,
president of Merck’s U.S. Human Health Division (USHH), announced at
the division’s administrative offices in New Wales, Pa. This investment demonstrates Merck’s commitment to maintaining its presence in southeastern Pennsylvania, said McGlynn. It will allow Merck to operate more efficiently while providing additional space to support the development of the growing number of products in the company’s research pipeline. USHH’s Pennsylvania expansion plan includes building a new 600,000-sq.-ft. (54,000-sq.-m.) headquarters. Merck will construct that facility on a 154-acre (62-hectare) site that it’s buying in eastern Montgomery County in Lower Gwynedd Township, Pa., near Philadelphia. USHH will begin building its new headquarters in mid-2005, completing the process in about two years, according to Merck officials’ estimates. When the new facility is finished, the division’s operational base will relocate from its current location in Upper Gwynedd Township. USHH will use its roomy new headquarters to consolidate all of its U.S. sales and marketing divisions, said McGlynn. Merck will relocate 1,600 existing sales and marketing positions to the new site, which the company says could later be expanded to accommodate up to 1 million sq. ft. (90,000 sq. m.) of space. The divisional headquarters project lacked the very wide-ranging focus of Merck’s high-profile search for its 300-employee, $300-million vaccine plant. The company looked at more than 100 sites in 16 states before picking Durham, N.C., as the plant location early this year. (For more details, see North Carolina’s $36M Incentives Injection Catches Merck’s $300M Vaccine Plant, the January 2004
This time around, though, Merck’s USHH division concentrated its search solely on southeast Pennsylvania, company officials said.
Upper Gwynedd
Merck will build the new USHH headquarters at a site that was once owned by Moore Products, a manufacturer of measurement and process control equipment. Siemens acquired Moore Products in 2002. Siemens Energy & Automation (SEA) is currently the lone occupant in the building, which Conshohocken-based Preferred Real Estate Investments acquired about a year ago.
Getting R&D Jobs The Siemens unit will remain at the new headquarters site. Merck will tear down all of the facility except the space that SEA is now occupying. The company will then rebuild an entirely new facility in Lower Gwynedd, with Siemens leasing its current space. But Upper Gwynedd, too, will be part of Merck’s expansion: The township may be losing a headquarters to its neighbor, but it’s gaining a very big infusion of high-end jobs. Once USHH moves into its new headquarters in Lower Gwynedd, the Merck division will add 800 new positions in Upper Gwynedd. All of the jobs will be in R&D. Those additions come on the heels of Merck’s two other previously announced expansions in Upper Gwynedd. The company has already completed a new 350,000-sq.-ft. (31,500-sq.-m.) R&D operation at its West Point location, where it plans to add another 125,000 sq. ft. (11,250 sq. m.). And this fall, Merck will break ground on a 375,000-sq.-ft. (33,750-sq.-m.) expansion at its 400-acre (160-hectare) complex that’s known within the company as Upper Gwynedd. Nonetheless, the news of 800 additional R&D jobs made for particularly good news for the area. Though Merck’s other recently announced expansions are very big projects, those projects aren’t expected to add any new local jobs. What’s more, the company announced in November of last year that it was cutting costs by laying off 4,400 workers 7 percent of its worldwide labor force. The Whitehouse Station, N.J.-based company has struggled recently as its biggest-selling drugs have lost patent protection, opening the door to competition from price-cutting generic manufacturers. Merck’s Zocor, a highly popular cholesterol fighter, has come off patent in many European markets, and it will lose its U.S. protection in 2006.
State Providing The state is facilitating Merck’s newest southeastern Pennsylvania expansion with a $5.4-million incentive package.
Subsidies of $5.4 Million
USHH is receiving a $1.25-million grant from the Pennsylvania Infrastructure Development Program and a $1-million award from the Opportunity Grant Program (which rewards job creation or preservation). In addition, Pennsylvania Department of Community and Economic Development officials said that the Merck division is getting $2.4 million in job-creation tax credits and $750,000 in job-training assistance. This commitment not only means 800 new jobs for the area, said Gov. Ed Rendell (D). It also paves the way for increased economic growth and activity, marking a new day for Montgomery County and the entire region. Merck employs some 14,000 workers in Pennsylvania. About 12,000 of those positions are in Montgomery County.
Agrium Moving Ahead with $24M Alberta Expansion by JACK LYNE, Site Selection Executive Editor of Interactive Publishing
CALGARY, Alberta Agrium
Products won’t be shuttering Canada’s largest fertilizer plant
after all. After getting final provincial approval, the manufacturer
of agricultural nutrients and industrial products has decided instead
to move forward with an $18.3-mllion expansion of its phosphate fertilizer
operation in the Edmonton metro. (All
figures in Project Watch have been converted to U.S. dollars.)
At public hearings in February, Agrium announced that it would close the Alberta facility if its expansion didn’t receive regulatory approval. The shutdown would’ve put 400 employees out of work at the plant, located on the banks North Saskatchewan River about eight miles (13 kilometers) south of the city of Redwater. But now that won’t be necessary. The Alberta Natural Resources Conservation Board (NRCB) gave the expansion conditional approval on Aug. 9 in Calgary. We are very pleased that the regulatory process has confirmed that our project is in the public interest, and we can now move forward with our extension, said Alex Watson, general manager of Agrium’s operations in Redwater and Saskatchewan. With the NRCB’s approval, a giant pile of gypsum will now get even bigger. Gypsum is a byproduct in phosphate fertilizer production.
The company’s expansion plan calls for adding another 300 acres (120 hectares) to the pile area in order to add more cooling storage ponds. The existing ponds are at capacity and must be replaced, Agrium says. The huge gypsum piles reflect the sizable capacity of the Redwater operation, which has hit record production levels for the last five years. The plant now turns out 682,000 tons (620,000 metric tons) of phosphate a year along with some 1.87 tons (1.7 million metric tons) of gypsum.
Residents Cited
The Redwater plant has been operating for 33 years. Calgary-based Agrium took over the plant in 1996 after it acquired rival firm Viridian. In addition to its Redwater and Saskatchewan operations, the company has two other Alberta plants in the cities of Carseland and Granum.
Health Concerns The Redwater expansion faced stiff opposition from residents living near the facility. That neighborhood on the North Saskatchewan River’s south bank is in an area that was rezoned for heavy industry three years ago. The edges of the river along that stretch are heavily industrialized. Air Liquide, Dow, Oxy Vinyl and Shell all have refineries across the river from the Redwater plant. Residents near the Redwater plant pressured the NRCB for the public hearings in February on Agrium’s expansion. They voiced a number of health-related concerns during those sessions, many of them related to the fluoride contained in gypsum. Fluoride emissions, they contended, were poisoning their water and making them and their cattle ill. Noise and low-level radiation from the plant were also among prominent complaints. In addition, some neighboring residents said that the proximity of Agrium’s plant was severely reducing their property values. Agrium responded by pointing out that the new gypsum cooling ponds would actually be farther away from nearby residents’ homes than the existing ponds. ‘Conditions Attached’ to Approval
Overall, the project is unlikely to result in significant adverse environmental effects, provided that the design specifications and mitigation measures proposed by Agrium and the recommendations and conditions of the panel are implemented, the board said in its ruling. Significantly, though, the board concluded that Agrium didn’t have a full grasp of the plant’s environmental issues. The panel does not believe that Agrium fully understands the source and impacts of fluoride emissions from the plant, the ruling said. That’s where the NRCB’s conditions attached to the approval come into play. The board is requiring the company to undertake studies to improve its understanding of the factors contributing to fluoride emissions. The board’s other conditions include demanding Agrium to develop a credible procedure for emission estimates and risk assessment and to develop and implement a mitigation plan [for the existing gypsum stack] that is to [Alberta Environmental Protection’s] satisfaction. The board also answered another concern of the plant’s neighbors, stressing the need for Agrium to renew its commitment to resolve its neighbors’ noise concerns. The company says that it doesn’t anticipate any difficulty in addressing any of the board’s conditions. This decision contributes to the long-term viability of the facility, said Watson. The approved plan will provide enough gypsum storage space to satisfy the Redwater plant’s needs for 25 years, he added. So Agrium is now definitely moving ahead with its expansion. And almost just as surely, neighbors’ complaints will keep coming.
Expansion Draws Both Bouquets, Barbs by JACK LYNE, Site Selection Executive Editor of Interactive Publishing
HALIFAX, Nova Scotia
Michelin’s plan to invest some $31 million
in two of its existing plants in Nova Scotia
certainly looks like very good news for the province’s
economy. Nonetheless, the incentives connected to the project have
rapidly turned the expansions into a political football.
Michelin will invest $19 million in its plant in Bridgewater and another $12 million in its plant in Waterville, the French-based tire manufacturer announced in Halifax on Aug. 3rd. Both investments will be focused on equipment upgrades. With the new equipment, both plants will begin making larger dimension tires for light trucks, Michelin officials said. The new equipment will also give the operations greater flexibility in manufacturing output. The upgrades will be coming to two very large operations. Bridgewater operation has some 1,100 employees, while the Waterville plant has about 1,000. And Michelin employs about 1,250 more Nova Scotians at its plant in Granton. All three plants are major economic cornerstones in the small towns in which they’re located. Bridgewater has some 8,000 residents, while Granton has about 6,500, and Waterville has some 15,000. More than three thousand Nova Scotians and their families depend on Michelin for their livelihoods, Nova Scotia Economic Development Minister Ernest Fage said at the expansions’ announcement. This [incentives] contribution will help secure those jobs, as well as expanding the existing work force. Michelin North America General Counsel and Secretary George Sutherland characterized the expansions as a strong endorsement of the plants’ performance.
These investments demonstrate the ability of Nova Scotia employees to deliver on quality and price in a very competitive market, Sutherland noted. They are good news for our Bridgewater and Waterville facilities.
Incentives: That’s the Rub
Not so fast, countered critics from the New Democratic Party, which
opposes Nova Scotia Premier John Hamm’s current Tory Party administration.
The province’s agreement with Michelin amounted to a scandal,
charged Nova Scotia Legislative Assembly member Howard Epstein,
a frequent NDP commentator on economic development. The NDP’s criticism is centered on Nova Scotia’s $3 million in incentives for the two Michelin expansions. Those subsidies, as the NDP has repeatedly pointed out, are not tied to job creation. And that’s left Hamm in an uncomfortable spot. De-emphasizing incentives that weren’t tied to job creation was one of Hamm’s campaign promises in 1999, during his first successful run for Nova Scotia’s top governmental job. In addition, Michelin’s new subsidies come after the current government had already written off about $35.5 million in loans to the tire-maker. Those loans were converted to grants, though, only after Michelin met its targets for job creation and capital investment. Grants and loan write-offs continue to go out to businesses like Michelin that are already profitable, Epstein charged. The only acceptable subsidies for corporate expansions, he maintained, are payroll rebates directly linked to newly created jobs.
The company hasn’t ever mentioned job creation as part of the projects. Michelin officials have estimated that the expansions may add from 16 to 24 new jobs at each plant. But the company isn’t guaranteeing that either project will result in any new jobs. What appears to have happened is that the Hamm government realized that the realities of global competition often trump voter-friendly campaign pledges. With the new equipment, the Bridgewater and Waterville plants will be able to begin making the kind of tires used on sport utility vehicles a hot-selling commodity in today’s market. And having that added ability, Hamm has apparently grasped, makes the future much more solid for those plants and for their sizable Nova Scotian work forces. Given that Michelin’s plants must compete internationally for investment capital, said Fage, we’re proving that Nova Scotia can successfully compete on the global market. Without incentives to compete for these upgrades, the projects would’ve gone elsewhere. Michelin’s Sutherland sounded a similar note. Michelin and our Nova Scotia plants compete on a global basis with tire companies that manufacture throughout the world, Sutherland said. We very much appreciate the province’s recognition of this. Fage also maintained that Michelin’s subsidies were congruent with the Hamm administration’s policy. This investment in the economies of the Annapolis Valley and South Shore reflects the priority that our growth strategy, Opportunities for Prosperity, puts on strengthening our rural economies, he said. Michelin won’t start getting any of its Nova Scotia incentives until the new equipment has been added and both plants are using it in commercial production. The company is projecting that equipment installation will begin in May of 2005, with production beginning in September of 2005.
![]() ![]()
©2004 Conway Data, Inc. All
rights reserved. Data is from many sources and is not warranted
to be accurate or current.
|